Advertisement

Related Videos

Opening Session Panel Discussion

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Amit Sanyal, MD: A Clinician’s Perspective

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




May
01
Today In Oncology
Belzutifan–Lenvatinib Outperforms Cabozantinib After Checkpoint Inhibitors in Advanced Renal Cell Carcinoma
Acupuncture for Nocturia in Survivors of Prostate Cancer
Metabolic Tumor Volume Predicts CAR T-Cell Therapy Response in LBCL
Can Pesticide Exposure Increase Early-Onset Colorectal Cancer Risk
AI-Powered, Next-Generation Sequencing Blood-Based Assay Evaluated for Detection of Post-HCT Relapse in AML and MDS
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo